This topic contains a solution. Click here to go to the answer

Author Question: Which of the following sets of substituents are all deactivating groups in electrophilic aromatic ... (Read 51 times)

washai

  • Hero Member
  • *****
  • Posts: 523
Which of the following sets of substituents are all deactivating groups in electrophilic aromatic substitution reactions?
 a. Cl, CN, NO2
  b. Cl, NH2, CH3
  c. CH3, OCH3, COCH3
  d. CH3, NH2, OCH3

Question 2

Which of the following sets of substituents are all activating groups in electrophilic aromatic substitution reactions?
 a. Br, NH2, CH3
  b. CH3, NH2, OCH3
  c. OH, COCH3, CH3,
  d. Br, CN, NO2



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kkenney

  • Sr. Member
  • ****
  • Posts: 352
Answer to Question 1

a

Answer to Question 2

b





 

Did you know?

As the western states of America were settled, pioneers often had to drink rancid water from ponds and other sources. This often resulted in chronic diarrhea, causing many cases of dehydration and death that could have been avoided if clean water had been available.

Did you know?

Signs of depression include feeling sad most of the time for 2 weeks or longer; loss of interest in things normally enjoyed; lack of energy; sleep and appetite disturbances; weight changes; feelings of hopelessness, helplessness, or worthlessness; an inability to make decisions; and thoughts of death and suicide.

Did you know?

Signs and symptoms of a drug overdose include losing consciousness, fever or sweating, breathing problems, abnormal pulse, and changes in skin color.

Did you know?

Hypertension is a silent killer because it is deadly and has no significant early symptoms. The danger from hypertension is the extra load on the heart, which can lead to hypertensive heart disease and kidney damage. This occurs without any major symptoms until the high blood pressure becomes extreme. Regular blood pressure checks are an important method of catching hypertension before it can kill you.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library